The success of Sildenafil initially drove a surge for pharma, however recent developments present a complicated outlook for investors. Off-patent versions are eating into profits, and ongoing legal battles add further https://rajanggfk695817.estate-blog.com/40014423/viagra-and-big-pharma-a-risky-bet